1World Health Organization. The global burden of disease: 2004 update [R] . WHO, 2008.
2Casas JP, Shah J, Hingorani AD, et al. C-reactive protein and coronary heart disease: a critical review [J].J Intern Med, 2008, 264 (4): 295-314.
3Kuller LH, Tracy RP, Shaten J, et al. Meilahn, Relation of C-reactive protein and coronary heart disease control study; Multiple Risk Factor Intervention Trial [J] . Am J Epidemiol, 1996, 144 (6) : 537-547.
4David I, Rongwei Fu, Michele F, et al. C-Reactive Protein as a Risk Factor for Coronary Heart Disease: Meta-analyses for the U. S. Preventive Services Task Force [J]. Annals of Internal Medicine, 2009, 151:483-495.
5Tina S, Paul N, Liam S, et al. Ancestry as a Determinant of Mean Population C-Reactive Protein Values : in the MRFITnested case- A Systematic Review and Implications for Cardiovas-cular Risk Prediction[J]. Circ Cardiovasc Genet, 2010, 3: 436-444.
6Xingwang Ye, Zhijie Yu, Huaixing Li, et al. Distributions of C-Reactive Protein and its Association With Metabolic Syndrome in Mid- dle-Aged and Older Chinese People [J]. J Am Coil Cardiol, 2007, 49: 1798-1805.
7CRP CHD Geneties Collaboration. Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: jud- ging causality by Mendelian randomisation[J].Eur J Epidemiol, 2008, 23 (8): 531-540.
8Claudio V, Tina S, Juan P, Casas, et al. Bayesian Meta-Analysis of Genetic Association Studies with Different Sets of Markers [J]. The American Journal of Human Genetics, 2008, 82:859-872.
9Debbie AL, Roger MH, Nic JT, et al. The Association of C-Reactive Protein and CRP Genotypewith Coronary Heart Disease: Find- ings from Five Studies with 4, 610 Cases amongst 18, 637 Participants [J].plosone, 2008, 3 (8) : 3011.
6NAKAMURA Y, SHIMADA K, FUKUDA D, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease[J]. Heart, 2004, 90(5): 528-533.
7SCHEME P E, WILLIAMS S, FOGLANO M, et al. A novel serum protein similar to Clq produced exclusively in adipocyles[ J]. J Biol Chem, 1995, 270(45) : 26 746 -26 749.
8YAMANCHI L, KOMAN J, HO Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects [ J ]. Nature, 2003, 423(6 491 ) : 762 -769.
9CHINETTI G, ZAMADSKI C, FRUCHART J C, et al. Expression of adipnecfin receptor in human macrophages and regulation by agonists of the nuclear receptor PPAR alpha, PPAR gamma, and LXR[J]. Biochem Biophys Res Commun, 2004, 314(1): 151 -158.
10ISHIKAWA Y, AKASKA Y, ISHII T, et al. Changes in the distribution pattern of gelatin - binding protein of 28 Kda( adiponeetin) in myocardial remodeling after ischaemic injury [ J ]. Histopathology, 2003, 42 ( 1 ) : 43.
1Boushey C J, Beresford SA A, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA, 1995,274 ( 13 ) : 1049-1057.
2Hofbauer LC, Khosla S, Dunstan CR. The roles of stboprotegerln and osteoprotegerin ligand in the paracrineregulation of bone resorption. Journal of Bone and Mineral Research,2008,12 ( 1 ) : 211-212.
3Eryd SA, Smith JG, Melander O, et al. Incidence of coronary events and case fatality rate in relation to blood lymphocyte and neutrophil counts[J]. Arterioscler Thromb Vasc Biol, 2012, 32(2) : 533 -539.
4Sena N, Afsarb B, Ozcanc F, et al. The neutrophil to lymphocyte ra- tio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST - elevated myocardial infarction undergoing primary coronary intervention[ J ]. Atherosclerosis, 2013, 228(1) :203 -210.
5Azab B, Shah N, Akerman M, et al. Value of platelet/lymphocyte ratio as a predicator of all - cause after non - ST - elevation myocardi- al infarction [ J]. J Thrombo Thrombolys, 2012, 34 (3) : 326 - 334.
6Cademartiri F, Arcadi T, Tarantini G, et al. Coronary atherosclero- sis : the predictor of cardiovascular events [ J ]. Cardiology,2014, 128 (4) : 301 -303.
7Kaplan ZS,Jackson SP. The role of platelets in atherothrombosis[ J]. Hematology, 2011,2011 (1) : 51 -61.
8Kaya MG. Inflammation and coronary artery disease : as a new biomar- ker neutrophil/lymphocyte ratio [ J]. Urk Kardiyol Dern Ars, 2013, 41(3) :191 - 192.
